semaglutide blindness risk Big headlines this past week about and due to something called NAION (nonarteritic anterior ischemic optic neuropathy). We spoke with our buddy Dr. Brugger, an ophthalmologist, all about it. Take Breaking Med
Description
[DOI] [PubMed] [Google Scholar] 67.Zomer H.D., Cooke P.S
So the question is: Is there going to be increased pressure on the starting doses of tirzepatide and semaglutide? The restrictions on compounded GLP-1 products come as concerns about existing shortages are bubbling
Summary Mounjaro effectively manages weight and type 2 diabetes when used appropriately
Injectable is preferred as the oral form is methylated and harder on the liver, partially negating one of Primobolans key advantages
